Sangamo Therapeutics

Mark McClung, Executive Vice President and Chief Operating Officer

April 21 | 11:15am | Gaudi 3 Ballroom

Richmond, CA

(NASDAQ: SGMO)

In-Person Presentation

Sangamo Therapeutics is a genomic medicine company that seeks to help millions of people who suffer from severe diseases for which today’s medicine can only offer symptom management at best. Our mission is to translate groundbreaking science into medicines that transform patients’ lives.

www.sangamo.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions